NCT/Study#
NCT04720664 /
OASIS
OASIS: Phase II Trial Of Oral SM-88 In Patients With Metastatic Hormone Receptor-Positive HER2-Negative (HR+/HER2-) Breast Cancer.
DISEASE GROUP:
Breast Cancer Clinical Trials
current phase:
Phase II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
